| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/05/2009 | CA2694635A1 Uses of trientine and penicillamine as countermeasures to metal contamination |
| 02/05/2009 | CA2694495A1 Capsule composition for use as immunogen against campylobacter jejuni |
| 02/05/2009 | CA2694454A1 Chemokine analogs |
| 02/05/2009 | CA2694127A1 Idiotypic vaccine |
| 02/05/2009 | CA2694055A1 Novel antibodies |
| 02/05/2009 | CA2693266A1 Novel synthetic agonists of tlr9 |
| 02/05/2009 | CA2693208A1 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 02/04/2009 | EP2020604A1 Ligand for G-protein coupled receptor FPRL2 and uses thereof |
| 02/04/2009 | EP2020444A1 Defective non-integrative lentiviral transfer vectors for vaccines |
| 02/04/2009 | EP2020419A1 Anti ephB4 antibody fragments |
| 02/04/2009 | EP2020241A1 Cerebral vasospasm inhibitor |
| 02/04/2009 | EP2020240A1 Methods and substances for the treatment of Alzheimer's |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2019865A1 Stable vaccine formulation |
| 02/04/2009 | EP2019863A1 High-titer retroviral packaging cells |
| 02/04/2009 | EP2019856A1 Chemically defined culture medium for neisseria |
| 02/04/2009 | EP2019689A2 Pharmaceutical composition and vaccine against staphylococcal infections |
| 02/04/2009 | EP2019687A2 Vaccine against streptococci |
| 02/04/2009 | EP2019686A2 Combined mucosal and parenteral immunization against hiv |
| 02/04/2009 | EP2019685A2 Defective interfering virus |
| 02/04/2009 | EP2019684A2 Methods and compositions based on shiga toxin type 1 protein |
| 02/04/2009 | EP2019683A2 Administration of growth factors for the treatment of cns disorders |
| 02/04/2009 | EP2019594A2 Extract of r. miehei |
| 02/04/2009 | EP0881906B2 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 02/04/2009 | CN101360826A Anti-alpha2 integrin antibodies and their uses |
| 02/04/2009 | CN101360823A Recombinant multivalent vaccine |
| 02/04/2009 | CN101360821A Stabilizing formulations for recombinant viruses |
| 02/04/2009 | CN101360760A Biological materials and uses thereof |
| 02/04/2009 | CN101360758A Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 02/04/2009 | CN101360512A Food products comprising probiotic micro-organisms and antibodies |
| 02/04/2009 | CN101360511A Methods for inhibiting carcinogenesis and/or metastasis in an individual with endogenous c-met ligands and inhibitors |
| 02/04/2009 | CN101360510A Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| 02/04/2009 | CN101358225A Method for preparing high sialic acid content immune globulin antibody and application |
| 02/04/2009 | CN101358182A Recombinant baculovirus strain of porcine circovirus type 2 Cap protein expression, construction method and application thereof |
| 02/04/2009 | CN101357944A Anti-idio-typic antibody NP30 chimeric Fab fragment of japonicum, preparation method and application |
| 02/04/2009 | CN101357942A Monoclonal antibody, Fab antibody and application for neutralizing enterohemorrhagic escherichia coli o157:H7 shiga toxin II |
| 02/04/2009 | CN101357230A Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/04/2009 | CN101357229A Production technique of immunoglobulin compounding agent capable of preventing and treating pig diarrhea |
| 02/04/2009 | CN101357228A Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| 02/04/2009 | CN101357227A Senile dementia recombinant adenovirus gene vaccine and preparation method thereof |
| 02/04/2009 | CN101357226A Replication-deficient human type 3 adenovirus vaccine |
| 02/04/2009 | CN101357137A Use of a vitreoscilla filiformis lipopolysaccharide fraction as an agent for stimulating the synthesis of anti-microbial skin peptides |
| 02/04/2009 | CN100457914C Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 02/04/2009 | CN100457912C Recombinant Ag85B bacillus Calmette-Guerin vaccine |
| 02/04/2009 | CN100457907C Recombinant helicobacter pylori outer-membrane protein 15 |
| 02/04/2009 | CN100457901C Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 02/04/2009 | CN100457895C Mouse anti-human macrophage migration inhibiting factor monoclonal antibody and its application |
| 02/04/2009 | CN100457781C Antibodies against cancer |
| 02/04/2009 | CN100457780C Recombinant Plasmodium falciparum 175kD erythrocyte conjugated antigen functional region protein and its preparation and use |
| 02/04/2009 | CN100457181C Combination methods of inhibiting tumor growth with vascular endothelial growth factor receptor antagonist |
| 02/04/2009 | CN100457180C Medicine composition for treating allergic disease and method for preparing the same |
| 02/04/2009 | CN100457179C Method and composition for oral vaccination |
| 02/03/2009 | US7485712 A DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins; for the treatment of Alzheimer's disease and cancer, diagnostic kits and in vitro diagnostic methods for the diseases |
| 02/03/2009 | US7485710 Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof |
| 02/03/2009 | US7485708 Nucleic acids encoding ara h 3 polypeptides |
| 02/03/2009 | US7485702 Homogeneous preparations of IL-28A cysteine mutants |
| 02/03/2009 | US7485701 Homogeneous preparations of IL-28 and IL-29 |
| 02/03/2009 | US7485459 Human neuronal attachment factor-1 antibodies |
| 02/03/2009 | US7485456 Drug screening for a molecule capable of binding to NIK (nuclear factor kappa B inducing kinase); DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, isoforms, analogs, fragments and derivatives; gene expression |
| 02/03/2009 | US7485440 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
| 02/03/2009 | US7485438 Method of producing polyvalent antigens |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485422 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 02/03/2009 | US7485416 Contacting cell that produces SIRT1 Tat deacetylase polypeptide and an acetylated Tat polypeptide with a test agent; determining level of acetylated Tat polypeptide in cell compared to level of acetylated Tat polypeptide in a control cell; drug screening; human immunodeficiency virus infections |
| 02/03/2009 | US7485415 Sequence analysis of the tetravalent rotavirus vaccine |
| 02/03/2009 | US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions |
| 02/03/2009 | US7485318 Biodegradable carrier and method for preparation thereof |
| 02/03/2009 | US7485314 Induction of antigen specific immunologic tolerance |
| 02/03/2009 | US7485313 Administering an isolated and purified recombinant Chlamydia trachomatis pgp3 protein having its native amino acid conformation to elicit an immune response to a recombinant Chlamydia trachomatis pgp3 protein |
| 02/03/2009 | US7485312 Surface protein (HBsAg) variant of the hepatitis B virus |
| 02/03/2009 | US7485308 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 02/03/2009 | US7485307 Protein consisting of specific amino acid sequences or a homolog of the protein; catalyzes the formation of cystathionine and does not bind heme |
| 02/03/2009 | US7485306 Lutzomyia longipalpis polypeptides and methods of use |
| 02/03/2009 | US7485305 Polypeptide isolated from Dermatophagoides; use of polypeptides, polynucleotides and/or antibodies in therapy and diagnosis of allergic disorders; genetic engineering |
| 02/03/2009 | US7485304 Non-toxic mucosal adjuvant |
| 02/03/2009 | US7485303 Pharmaceutical composition of F(ab')2 antibody fragments |
| 02/03/2009 | US7485302 Treatment with anti-ErbB2 antibodies and chemotherapeutic agents |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | US7485300 Cancerous disease modifying antibodies |
| 02/03/2009 | US7485299 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 02/03/2009 | US7485298 Diagnosis and treatment of human dormancy-related sequellae |
| 02/03/2009 | US7485297 Method of inhibition of vascular development using an antibody |
| 02/03/2009 | US7485296 Using monoclonal antibodies specific for prostate stem cell antigen (PSCA) for use in diagnosis and treatment of cell proliferfative disorders; immunodiagnostics; immunotherapy |
| 02/03/2009 | US7485292 Administering echovirus which recognizes integrin alpha 2 beta 1 for infectivity of the cells such that at least one of the cells are killed by the virus, wherein the abnormal cell is a cancer cell expressing alpha 2 beta 1; screening viruses |
| 02/03/2009 | CA2361377C Novel mucosal delivery system |
| 02/03/2009 | CA2223567C Modified meningococcal polysaccharide conjugate vaccines |
| 02/03/2009 | CA2185565C Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 02/03/2009 | CA2150925C Improved synthesis of polymer bio-active conjugates |
| 01/29/2009 | WO2009015345A1 Pharmaceutical compositions comprising fc fusion proteins |
| 01/29/2009 | WO2009015284A2 Il-18 receptor antigen binding proteins |
| 01/29/2009 | WO2009015279A2 Agents and methods for inhibition of airway hyperresponsiveness |
| 01/29/2009 | WO2009015087A2 Compositions and methods for treatment of trauma |
| 01/29/2009 | WO2009015063A2 Methods and compositions for treating fibrosis related disorders using il-17 antagonists |
| 01/29/2009 | WO2009014887A2 Stabilized immune modulatory rna (simra) compounds |
| 01/29/2009 | WO2009014835A2 Modified toxins |
| 01/29/2009 | WO2009014745A1 Antibodies to cd200 and uses thereof in inhibiting immune responses |
| 01/29/2009 | WO2009014708A2 Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| 01/29/2009 | WO2009014638A2 Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1 |
| 01/29/2009 | WO2009014560A1 Methods and compositions for the treatment of pathogenic deseases |
| 01/29/2009 | WO2009014456A1 Materials and methods for sperm sex selection |